BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22554548)

  • 1. Melanoma molecular classes and prognosis in the postgenomic era.
    Tremante E; Ginebri A; Lo Monaco E; Frascione P; Di Filippo F; Terrenato I; Benevolo M; Mottolese M; Pescarmona E; Visca P; Natali PG; Giacomini P
    Lancet Oncol; 2012 May; 13(5):e205-11. PubMed ID: 22554548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers in melanoma.
    Kashani-Sabet M
    Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G
    Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biomarkers of prognosis in melanoma: how far are we from the clinic?
    Schramm SJ; Menzies AM; Mann GJ
    Melanoma Res; 2013 Dec; 23(6):423-5. PubMed ID: 24165033
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic tissue markers in melanoma.
    Moore DA; Pringle JH; Saldanha GS
    Histopathology; 2012 Apr; 60(5):679-89. PubMed ID: 21880059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
    Winnepenninckx V; van den Oord JJ
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma".
    Torres-Mora J; Dry S; Li X; Binder S; Amin M; Folpe AL
    Am J Surg Pathol; 2014 Jan; 38(1):94-105. PubMed ID: 24145644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.
    Jönsson G; Busch C; Knappskog S; Geisler J; Miletic H; Ringnér M; Lillehaug JR; Borg A; Lønning PE
    Clin Cancer Res; 2010 Jul; 16(13):3356-67. PubMed ID: 20460471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma progression, gene expression and DNA microarrays.
    Hoek KS
    G Ital Dermatol Venereol; 2009 Feb; 144(1):39-49. PubMed ID: 19218910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic classification of melanoma cells by phenotype-specific gene expression mapping.
    Widmer DS; Cheng PF; Eichhoff OM; Belloni BC; Zipser MC; Schlegel NC; Javelaud D; Mauviel A; Dummer R; Hoek KS
    Pigment Cell Melanoma Res; 2012 May; 25(3):343-53. PubMed ID: 22336146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction.
    Lewis TB; Robison JE; Bastien R; Milash B; Boucher K; Samlowski WE; Leachman SA; Dirk Noyes R; Wittwer CT; Perreard L; Bernard PS
    Cancer; 2005 Oct; 104(8):1678-86. PubMed ID: 16116595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting clinical outcome through molecular profiling in stage III melanoma.
    John T; Black MA; Toro TT; Leader D; Gedye CA; Davis ID; Guilford PJ; Cebon JS
    Clin Cancer Res; 2008 Aug; 14(16):5173-80. PubMed ID: 18698035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnostics in melanoma.
    Carlson JA; Ross JS; Slominski A; Linette G; Mysliborski J; Hill J; Mihm M
    J Am Acad Dermatol; 2005 May; 52(5):743-75; quiz 775-8. PubMed ID: 15858465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
    Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
    Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular markers associated to prognosis of melanoma].
    Heenen M; Laporte M
    Ann Dermatol Venereol; 2003 Nov; 130(11):1025-31. PubMed ID: 14724537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The classification of cutaneous melanoma.
    Duncan LM
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):501-13, ix. PubMed ID: 19464599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular staging of melanoma.
    Shivers S; Alsarraj M; Guiliano R; Jakub J; Pendas S; Reintgen D
    Ann Surg Oncol; 2004 Nov; 11(11):953-4. PubMed ID: 15525822
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic signs in melanoma: state of the art.
    Lomuto M; Calabrese P; Giuliani A
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):291-300. PubMed ID: 15096138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.